Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Vir Biotechnology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- −16 vs. Q2 2024
- Shares held
- 87.6M
- +16.1M (+22.4%) vs. Q2 2024
- Total value
- $656.3M
- +$19.5M (+3.1%) vs. Q2 2024
- New holders
- 22
- 77 more added
- Sold out
- 38
- 67 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 237 | $1.49B |
| Q1 2026 | 252 | $1.25B |
| Q4 2025 | 218 | $696.5M |
| Q3 2025 | 213 | $610.8M |
| Q2 2025 | 213 | $558.5M |
| Q1 2025 | 234 | $604.5M |
| Q4 2024 | 208 | $652.0M |
| Q3 2024 | 197 | $656.3M |
| Q2 2024 | 215 | $783.1M |
| Q1 2024 | 210 | $901.0M |
| Q4 2023 | 207 | $887.2M |
| Q3 2023 | 215 | $827.4M |
| Q2 2023 | 227 | $2.23B |
| Q1 2023 | 234 | $2.06B |
| Q4 2022 | 225 | $2.18B |
| Q3 2022 | 221 | $1.68B |
| Q2 2022 | 214 | $2.20B |
| Q1 2022 | 204 | $2.09B |
| Q4 2021 | 210 | $3.25B |
| Q3 2021 | 175 | $3.24B |
| Q2 2021 | 166 | $3.64B |
| Q1 2021 | 157 | $3.87B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Raymond James & Associates | 0 | $0 | 0.00% | −74,113−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −48,399−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −48,294−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −46,087−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −46,222−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −35,476−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −29,755−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −28,900−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −27,198−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −26,917−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,428−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −19,572−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −19,224−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −18,959−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −17,419−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −15,751−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −13,306−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −12,573−100.0% | Sold out |
| Pinnacle Wealth Planning Services, Inc. | 0 | $0 | 0.00% | −11,333−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −10,828−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −10,167−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −10,148−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −5,600−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −3,541−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,028−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −320−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Harbor Investment Advisory, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |